A C 2v Symmetry Linker With Built‐In Hydroxamic Handle for the Macrocyclization of Thiol‐Containing Peptide Sequences
Journal of Peptide Science · 2026-12 · 32 (12)
DOI: 10.1002/psc.70151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Peptide Science, online erschienen am 16.11.2026. Verfasst von Francesca Bordignon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze Molecolari e Nanosistemi, Università Ca' Foscari Venezia, Mestre Venezia, Italy. Hauptthemen laut MEDLINE: Hydroxamic Acids, Sulfhydryl Compounds, Peptides, Macrocyclic Compounds. Die Arbeit nennt 51 Literaturangaben. Gefördert von: National Recovery and Resilience Plan (PNRR) and the European Union-Next Generation-EU, Ministry of University and Research (MUR) of Italy.
Abstract (Originalsprache)
Macrocyclic peptides are promising modalities for metalloprotein inhibition, yet candidates identified via combinatorial display platforms often require post‐selection chemical modification to introduce metal‐chelating groups for optimal potency. Here, we report two C 2v symmetry stapling linkers featuring an integrated hydroxamic acid handle and dual thiol‐reactive groups for the macrocyclization of genetically encoded peptides. Although the 2,3‐dibromomaleimide derivative showed high aqueous solubility and reactivity, it underwent severe degradation that compromised the hydroxamic acid functionality. In contrast, the 1,3‐ bis (bromomethyl)benzene derivative exhibited significantly greater stability. Chromatographic and mass spectrometry‐based kinetic analyses revealed that bis ‐cysteine peptides undergo rapid, clean, and quantitative macrocyclization to yield a single macrocyclic product, whereas single‐cysteine sequences yield monovalent thioether intermediates alongside a series of macrocyclic side‐products resulting from secondary reactions with less nucleophilic residues, such as lysine amine or serine hydroxyl groups. Inhibition studies on two metalloenzymes with the bis ‐cysteine macrocyclic peptide confirmed that the hydroxamic acid moiety remains fully capable of accessing the active‐site metal to block enzymatic activity. Integrating these metal‐chelating linkers with display technologies and macrocyclic libraries could provide a robust platform to rapidly generate potent, highly specific metalloprotein inhibitors, where the peptide motif acts as a secondary recognition element to enhance selectivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dipartimento di Scienze Molecolari e Nanosistemi, Università Ca' Foscari Venezia, Mestre Venezia, Italy.
- Arzanya S.r.l., Padova, Italy.
- European Centre for Living Technology (ECLT), Venezia, Italy.
ORCID-Profile: Francesca Bordignon, Stefano Pluda, Ylenia Mazzocato, Alessandro Scarso, Alessandro Angelini
Förderung
- National Recovery and Resilience Plan (PNRR) and the European Union-Next Generation-EU
- Ministry of University and Research (MUR) of Italy
Zitieren
APA
Bordignon, F., Pluda, S., Mazzocato, Y., Scarso, A., & Angelini, A. (2026). A C 2v Symmetry Linker With Built‐In Hydroxamic Handle for the Macrocyclization of Thiol‐Containing Peptide Sequences. Journal of Peptide Science, 32(12). https://doi.org/10.1002/psc.70151
Vancouver
Bordignon F, Pluda S, Mazzocato Y, Scarso A, Angelini A. A C 2v Symmetry Linker With Built‐In Hydroxamic Handle for the Macrocyclization of Thiol‐Containing Peptide Sequences. Journal of Peptide Science. 2026;32(12). doi:10.1002/psc.70151
BibTeX
@article{Bordignon2026,
author = {Bordignon, Francesca and Pluda, Stefano and Mazzocato, Ylenia and Scarso, Alessandro and Angelini, Alessandro},
title = {A C 2v Symmetry Linker With Built‐In Hydroxamic Handle for the Macrocyclization of Thiol‐Containing Peptide Sequences},
journal = {Journal of Peptide Science},
year = {2026},
volume = {32},
number = {12},
doi = {10.1002/psc.70151}
}
EUVIMED